Abstract
Nanomedicine is the application of nanotechnology in the field of medicine, comprising the utilization of materials at the nanoscale for purposes such as disease diagnosis, prevention, and treatment. This commentary explores some of the applications, challenges, and developments in nanomedicine, with a specific emphasis on the pivotal role of lipid-based nanocarriers in drug delivery systems.Nanomedicine operates within the scale defined by the prefix 'nano', typically involving materials with at least one dimension ranging from 1 to 100 nanometers. Additionally, materials that fall outside the nanoscale range but still exhibit similar properties or phenomena due to specific dimensions are considered part of nanomedicine [1]. It is worth noting that the properties of these materials differ from the same materials on a larger scale. Moreover, the unique properties of nanomaterials arise from their increased surface area-to-volume ratio as material dimensions shrink, altering their interactions with the environment.
Reference13 articles.
1. FDA. (2015). Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology. https://www.fda. gov/regulatory-information/search-fda-guidance-documents/ considering-whether-fda-regulated-product-involves application-nanotechnology
2. Anselmo, A. C., & Mitragotri, S. (2015). A Review of Clinical Translation of Inorganic Nanoparticles. The AAPS Journal, 17(5), 1041–1054.
3. Anselmo, A. C., Mitragotri, S., & Samir Mitragotri, C. (2016). Nanoparticles in the clinic. Bioengineering & Translational Medicine, 1(1), 10–29.
4. Shan, X., Gong, X., Li, J., Wen, J., Li, Y., & Zhang, Z. (2022). Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica. B, 12(7), 3028–3048.
5. Germain, M., Caputo, F., Metcalfe, S., Tosi, G., Spring, K., Åslund, A. K. O., … & Schmid, R. (2020). Delivering the power of nanomedicine to patients today. Journal of Controlled Release, 326, 164–171.